Those companies spend far more money on marketing than R&D an they’re heavily reliant on US funded research — almost every erything they do starts with NIH funding.
Then we have, Most of this marketing money is directed at the physicians who do the prescribing, rather than consumers. As Oliver pointed out, drug companies spent more than $3 billion a year marketing to consumers in the U.S. in 2012, but an estimated $24 billion marketing directly to health care professionals.
$27B in marketing but the graphic shows over $65B in R&D?